Canakinumab takes steps towards sJIA market
19 September 2011
Alex Shimmings
Please Login to read the full article.
19 September 2011
Alex Shimmings
alex.shimmings@informa.com
Please Login to read the full article.
RELATED CONTENT
NEWS
- Panel urges FDA to reject Novartis gouty arthritis drug on safety concerns
- Discount prompts another NICE reprieve for RoActemra
- Actemra filed in US for earlier line use in rheumatoid arthritis
- NICE asks Roche to compare RoActemra with Kineret and Remicade in juvenile arthritis
FEATURES
Other Informa Features
EVENTS
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
18 June 2012
Boston Convention & Exhibition Center, Boston, MA
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
